Epstein-Barr virus-induced proteins. II. Analysis of surface polypeptides from EBV-producing and -superinfected cells by immunoprecipitation

scientific article published in April 1980

Epstein-Barr virus-induced proteins. II. Analysis of surface polypeptides from EBV-producing and -superinfected cells by immunoprecipitation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0042-6822(80)90107-5
P698PubMed publication ID6154378

P50authorHarald zur HausenQ75847
P2093author name stringYamamoto N
Georg B
Meuller-Lantzsch N
P2860cites workEnzymic iodination. A probe for accessible surface proteins of normal and neoplastic lymphocytesQ41833256
Monospecific immunoprecipitation of murine leukemia virus polyribosomes: identification of p30 protein-specific messenger RNAQ43587755
Antigen expression and colony formation of lymphoblastoid cell lines after superinfection with Epstein-Barr virusQ44143551
Differential reactivity of human serums with early antigens induced by Epstein-Barr virusQ44738097
Epstein-Barr virus-induced proteins. III. Analysis of polypeptides from P3HR-I-EBV-superinfected NC37 cells by immunoprecipitationQ45803746
Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. I. ImmunofluorescenceQ45818353
Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitroQ45820152
Appearance of Epstein-Barr virus-associated antigens in infected Raji cellsQ45821399
Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. II. Immunoelectron microscopyQ45826525
Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell linesQ45826585
Some factors affecting membrane immunofluorescence reactivity of burkitt lymphoma tissue culture cell linesQ47778661
A method of trace iodination of proteins for immunologic studiesQ70063670
Appearance of Early and Late Components of Epstein-Barr Virus-Associated Membrane Antigen in Daudi Cells Superinfected with P3HR-1 VirusQ28321593
Papain solubilization of the Epstein-Barr virus-induced membrane antigenQ36525389
Surface expression of murine leukemia virus structural polypeptides on host cell and the virionQ39510911
Epstein-Barr virus-induced membrane antigens: Immunochemical characterization of triton X-100 solubilized viral membrane antigens from EBV-superinfected raji cellsQ39558367
Ultraviolet inactivation of Epstein-Barr virus: Effect on synthesis of virus-associated antigensQ39952465
Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strainsQ39974180
Expression of Epstein-Barr-virus-associated membrane antigen in Raji cells superinfected with two different virus strainsQ39982169
Persisting oncogenic herpesvirus induced by the tumour promoter TPAQ40136715
Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cellsQ40209275
Analysis of early and late Epstein-Barr virus associated polypeptides by immunoprecipitationQ40248828
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectEpstein–Barr virusQ6900
P304page(s)401-411
P577publication date1980-04-01
P1433published inVirologyQ7934867
P1476titleEpstein-Barr virus-induced proteins. II. Analysis of surface polypeptides from EBV-producing and -superinfected cells by immunoprecipitation
P478volume102

Reverse relations

cites work (P2860)
Q70192050A sensitive Enzyme-Linked Immunosorbent Assay (ELISA) against the major EBV-associated antigens. I. Correlation between ELISA and immunofluorescence titers using purified antigens
Q40577317Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients
Q36911884An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins (gp350/300 and gp220/200)
Q64380675Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus
Q53954529B-lymphotropic papovavirus and possibility of infections in humans.
Q45802260Biochemical characterization of Epstein-Barr Virus membrane antigen associated glycoproteins
Q33926883Detection by monoclonal antibodies of an early membrane protein induced by Epstein-Barr virus
Q40131366Epstein-Barr Virus Antigens–A Challenge to Modern Biochemistry
Q45799685Epstein-Barr Virus induced proteins V: Comparison of EBV-specific polypeptides from different virus strains
Q36922358Epstein-Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells
Q35239753Epstein-Barr virus membrane antigens: characterization, distribution, and strain differences
Q45805407Epstein-Barr virus strain- and group-specific antigenic determinants detected by monoclonal antibodies
Q36888549Expression of the Epstein-Barr virus gp350/220 gene in rodent and primate cells
Q36923500Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo
Q35238352Identification of an Epstein-Barr virus nuclear antigen by fluoroimmunoelectrophoresis and radioimmunoelectrophoresis
Q36865571Identification of the Epstein-Barr virus gp85 gene
Q40079991Interaction of viruses with tumor promotors
Q36312811Mapping of polypeptides encoded by the Epstein-Barr virus genome in productive infection
Q45797947Purification of a protein (60K/58K) associated with the Epstein-Barr virus-induced early antigen complex in Raji cells
Q34254100Purified Epstein-Barr virus Mr 340,000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomes
Q41560957Restrictions upon epstein-barr virus infection of the leukemic cell are demonstrated in patients with hairy cell leukemia
Q40128299Strain-specific transcription and translation of the BamHI Z area of Epstein-Barr Virus.
Q36906049Synthesis and processing of the three major envelope glycoproteins of Epstein-Barr virus
Q36937184Two large virion envelope glycoproteins mediate Epstein-Barr virus binding to receptor-positive cells
Q36341310p105, an Epstein-Barr virus-induced, phosphonoacetic acid-insensitive glycoprotein target of the anti-Epstein-Barr virus immune response

Search more.